Correlation Between Cumberland Pharmaceuticals and Uranium Energy

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Cumberland Pharmaceuticals and Uranium Energy at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cumberland Pharmaceuticals and Uranium Energy into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cumberland Pharmaceuticals and Uranium Energy Corp, you can compare the effects of market volatilities on Cumberland Pharmaceuticals and Uranium Energy and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cumberland Pharmaceuticals with a short position of Uranium Energy. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cumberland Pharmaceuticals and Uranium Energy.

Diversification Opportunities for Cumberland Pharmaceuticals and Uranium Energy

-0.69
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Cumberland and Uranium is -0.69. Overlapping area represents the amount of risk that can be diversified away by holding Cumberland Pharmaceuticals and Uranium Energy Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Uranium Energy Corp and Cumberland Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cumberland Pharmaceuticals are associated (or correlated) with Uranium Energy. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Uranium Energy Corp has no effect on the direction of Cumberland Pharmaceuticals i.e., Cumberland Pharmaceuticals and Uranium Energy go up and down completely randomly.

Pair Corralation between Cumberland Pharmaceuticals and Uranium Energy

Given the investment horizon of 90 days Cumberland Pharmaceuticals is expected to under-perform the Uranium Energy. But the stock apears to be less risky and, when comparing its historical volatility, Cumberland Pharmaceuticals is 1.26 times less risky than Uranium Energy. The stock trades about 0.0 of its potential returns per unit of risk. The Uranium Energy Corp is currently generating about 0.04 of returns per unit of risk over similar time horizon. If you would invest  714.00  in Uranium Energy Corp on August 29, 2024 and sell it today you would earn a total of  95.00  from holding Uranium Energy Corp or generate 13.31% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Cumberland Pharmaceuticals  vs.  Uranium Energy Corp

 Performance 
       Timeline  
Cumberland Pharmaceuticals 

Risk-Adjusted Performance

1 of 100

 
Weak
 
Strong
Very Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Cumberland Pharmaceuticals are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of fairly strong forward indicators, Cumberland Pharmaceuticals is not utilizing all of its potentials. The latest stock price disturbance, may contribute to short-term losses for the investors.
Uranium Energy Corp 

Risk-Adjusted Performance

14 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Uranium Energy Corp are ranked lower than 14 (%) of all global equities and portfolios over the last 90 days. In spite of rather uncertain technical and fundamental indicators, Uranium Energy exhibited solid returns over the last few months and may actually be approaching a breakup point.

Cumberland Pharmaceuticals and Uranium Energy Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Cumberland Pharmaceuticals and Uranium Energy

The main advantage of trading using opposite Cumberland Pharmaceuticals and Uranium Energy positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cumberland Pharmaceuticals position performs unexpectedly, Uranium Energy can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Uranium Energy will offset losses from the drop in Uranium Energy's long position.
The idea behind Cumberland Pharmaceuticals and Uranium Energy Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.

Other Complementary Tools

Technical Analysis
Check basic technical indicators and analysis based on most latest market data
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets